Navigation Links
FDA Advisory Committee Recommends Approval of Qnexa®
Date:2/22/2012

ct eating behavior. In phase 2 and 3 clinical data to date, patients taking Qnexa have demonstrated statistically significant weight loss, glycemic control, and improvement in cardiovascular risk factors, when used in combination with a diet and lifestyle modification program.

About VIVUSVIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health.  The company's lead investigational product in clinical development, Qnexa, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators.  VIVUS received a Complete Response Letter, or CRL, to the initial Qnexa NDA on October 28, 2010.  We resubmitted the Qnexa NDA in October 2011, with an FDA action date of April 17, 2012.  Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea.  In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction, with an FDA action date of April 29, 2012.  For more information about the company, please visit www.vivus.com

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.  These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," predict," "opportunity" and "should," among others.  There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements.  These factors include, but are not limited to, the response from the United States Food and Drug Administration, or FDA, to our resubmission of the New Drug Application, or NDA, for
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Arena Pharmaceuticals Receives Notice from FDA of Advisory Committee Meeting for Lorcaserin
2. Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists
3. Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board
4. FDA to Review Potential New Use of XGEVA® (Denosumab) at Oncologic Drugs Advisory Committee Meeting
5. VIVUS Announces Date of FDA Advisory Committee Review of Qnexa for the Treatment of Obesity
6. Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board
7. FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexzas ADASUVE™
8. FDA Advisory Panel Recommends Against Approval of Champion® Heart Failure Management System for Patients With Heart Failure
9. Bayers Drospirenone-containing Combination Oral Contraceptives: FDA Advisory Committees Affirm Positive Benefit-risk Profile and Recommend an Update of Labels to Reflect Information From Available Studies
10. PrimeraDx Appoints Leroy Hood to its Scientific Advisory Board
11. Digital ArtForms Debuts iMedic3D, a Radically Different Approach to Radiology, at RSNA ‘11, and Announces the Addition of Dr. Eliot Siegel and Dr. David Kim to Its Advisory Board Members
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , August 29, 2014 ... Market by Product & Services (Equipment, Reagent, Primer, ... Application (Diagnostics, PCR, QPCR, Gene Synthesis, NGS, DNA, ... MarketsandMarkets, the global Oligonucleotide Synthesis Market is expected ... Million in 2014, growing at a CAGR of ...
(Date:8/29/2014)... Aug. 29, 2014  In part four ... a hospital pharmacy as a strategic asset, Mary ... leader for Cardinal Health,s Innovation Delivery Solutions business, discusses ... benefit both hospitals and patients. "Every hospital ... part of their job in a value-based healthcare world," ...
(Date:8/29/2014)... -- Research and Markets  has announced the addition ... Market 2014-2018" report to their offering. ... that connect, support, or surround bones. There are several ... cartilage, fascia, and other fibrous tissues. Repetitive use, accidents, ... result in wear and tear in these tissues. Orthopedic ...
Breaking Medicine Technology:Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 2Global Orthopedic Soft Tissue Repair Devices Market 2014-2018: Key Vendors are ArthroCare, Biomet, DePuy Synthes and Smith & Nephew 3
... RALEIGH, N.C., Sept. 6, 2011 BioDelivery Sciences ... positive preliminary results from its Phase 1 study ...  BDSI is seeking to develop and commercialize a ... (abuse deterrent agent) for the treatment of opioid ...
... NEW YORK, Sept. 6, 2011 ... new market research report is ... Emerging Pharmaceutical Market ... Between Domestic and International Pharmaceutical ...
Cached Medicine Technology:BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence 2BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence 3BioDelivery Sciences Announces Positive Results Supporting BEMA Buprenorphine/Naloxone Formulation for Opioid Dependence 4Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 2Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 3Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 4Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 5Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 6Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 7Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 8Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 9Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 10Emerging Pharmaceutical Market in India - Strategic Partnerships Between Domestic and International Pharmaceutical Players are the Driving Force 11
(Date:8/29/2014)... 30, 2014 AGH Healthy Happenings, a ... Doctors in Delaware at Atlantic General Hospital, are ... services. In addition to no-cost blood pressure screenings at ... aid care at local sports tournaments. , In ... staff provide free disease management and falls prevention workshops ...
(Date:8/29/2014)... Daily Gossip reveals in its Get Rid of Cold ... cold sores patient who suffered from this terrible health problem for ... to share her tips and advices, but also her experience with ... the Get Rid of Cold Sores Fast program says that she ... least 4 years outbreaks have become more frequent. , Ellie ...
(Date:8/29/2014)... The new review that can be read ... holistic system that will permanently eliminate the symptoms of this ... can achieve a cure in as fast as 30 to ... only about one week. , The Tinnitus Miracle review ... as mild hearing loss, pain in the ear and dizziness. ...
(Date:8/29/2014)... 29, 2014 The Nasal Polyps ... that the new program is actually based on ... was created by a former nasal polyps sufferer, ... the disturbing problem. Manuel Richards suffered from nasal ... system. , Learn more about Manuel Richards' ...
(Date:8/29/2014)... Indosoft, Inc., a leading provider of ... monthly per-port licensing of its Q-Suite 5.7 software. ... Indosoft has been successfully deploying and supporting its ACD ... centers around the world for more than a decade. ... clients another option which complements the widespread deployment of ...
Breaking Medicine News(10 mins):Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 2Health News:Doctors in Delaware from Atlantic General Hospital Offer No-Cost Services to Area Residents 3Health News:Get Rid of Cold Sores Fast Review Reveals Simple Way to Eliminate Cold Sores in 12 Hours 2Health News:Tinnitus Miracle Review Reveals How to Gain Tinnitus Relief in 7 Days 2Health News:Nasal Polyps Treatment Miracle Review Exposes New Natural and Permanent Healing Program 2Health News:Indosoft Offers Monthly Usage Licensing Terms 2
... Consensus Guideline Reached For Quantitative Polymerase Chain ReactionSALT LAKE ... and the American Association for Clinical ... guideline for a key laboratory method called qPCR (or ... of international scientists representing the medical and research fields. ...
... AdCare Health Systems, Inc. (NYSE AMEX: ADK ... and management company today reported financial results for its ... December 31, 2008 were $24,793,294 as compared to $23,667,756 ... The improvement was primarily due to increased rental charges ...
... alerting capabilities, delivering meaningful performance measurements and relevant operational data ... ... Plano, TX (PRWEB) March 31, 2009 -- ... - Corepoint Decisions . Corepoint Health,s latest product ...
... 31 Hanger Orthopedic Group, Inc. (NYSE: HGR ) ... operations for the first quarter ended March 31, 2009, on ... release announcing the results for the first quarter ended March ... of the market. The conference call is scheduled to begin ...
... provider of advanced, high-volume, document and payment processing ... signed an exclusive service provider agreement with iVu ... early detection of cancer and other disease states. ... BancTec,s growing Multi-Vendor Services Group."BancTec,s Multi-Vendor Services Group ...
... League biologist who researches viruses to determine how and why ... of Houston April 2. The lecture is free and ... University associate professor of ecology and evolutionary biology, will speak ... the Science and Engineering Classroom Building Auditorium. His talk ...
Cached Medicine News:Health News:International Scientists Secure Quality in Molecular Diagnostics 2Health News:International Scientists Secure Quality in Molecular Diagnostics 3Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 2Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 3Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 4Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 5Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 6Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 7Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 8Health News:AdCare Health Systems, Inc. Reports Financial Results for 2008 9Health News:Corepoint Health Launches New Product Suite Focused on Enhancing Healthcare Operations & Metrics 2Health News:Corepoint Health Launches New Product Suite Focused on Enhancing Healthcare Operations & Metrics 3Health News:Corepoint Health Launches New Product Suite Focused on Enhancing Healthcare Operations & Metrics 4Health News:Hanger Orthopedic Group, Inc. Announces First Quarter 2009 Earnings Release Conference Call 2Health News:iVu Imaging Selects BancTec's Multi-Vendor Services Group as Exclusive Service Provider for Intelligent Volumetric Ultrasound Equipment 2Health News:iVu Imaging Selects BancTec's Multi-Vendor Services Group as Exclusive Service Provider for Intelligent Volumetric Ultrasound Equipment 3Health News:Virus evolution topic of Darwin talk at UH April 2 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: